ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 21 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $657,000 | +28.8% | 32,699 | 0.0% | 0.14% | +24.3% |
| Q4 2016 | $510,000 | -22.7% | 32,699 | -35.3% | 0.11% | -25.0% |
| Q3 2016 | $660,000 | +90.8% | 50,556 | 0.0% | 0.15% | +87.3% |
| Q2 2016 | $346,000 | -27.6% | 50,556 | 0.0% | 0.08% | -30.1% |
| Q1 2016 | $478,000 | +165.6% | 50,556 | +183.1% | 0.11% | +175.6% |
| Q4 2015 | $180,000 | – | 17,857 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |